68Ga-NY104 PET/CT

DIAGNOSTIC_TEST5 trials

Sponsors

Peking Union Medical College Hospital

Conditions

Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma

Phase 2

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Peking Union Medical College HospitalClear Cell Renal Cell Carcinoma

Start: 2023-08-01End: 2025-07-01Target: 40Updated: 2023-07-13

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Peking Union Medical College HospitalClear Cell Renal Cell Carcinoma

Start: 2023-08-01End: 2025-07-01Target: 63Updated: 2023-07-13

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Peking Union Medical College HospitalMetastatic Clear Cell Renal Cell Carcinoma

Start: 2023-08-01End: 2025-07-01Target: 39Updated: 2023-07-24

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Peking Union Medical College HospitalRenal Cell Carcinoma

Start: 2021-12-01End: 2023-07-01Target: 46Updated: 2023-06-15

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

RecruitingNCT06613269

Peking Union Medical College HospitalClear Cell Renal Cell Carcinoma

Start: 2024-03-27End: 2028-09-30Target: 40Updated: 2024-09-27

Related Papers

Comparison of <sup>68</sup> Ga-NY104 PET/CT with <sup>18</sup> F-FDG PET/CT in patients with metastatic clear cell renal cell carcinoma (NYCRM): A prospective, comparative phase II study.

Journal of Clinical Oncology2025-05-28

Diagnostic efficacy of [<sup>68</sup>Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma.

2024-06-257 citations